More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
NHS develops dashboard to identify possible over-prescribing of prednisolone The dashboard calculates the total cumulative dose of prednisolone prescribed to patients in England in the past 12 months, allowing those at risk to be considered for alternative treatment methods.…
More than 90% of lung disease patients say community pharmacy services are vital, survey finds Results of a survey by the Taskforce for Lung Health found that patients valued community pharmacies because they are close to home, there is no need to make an appointment and they have convenient opening times.…
Both using and stopping asthma medicines in pregnancy linked with poor outcomes Researchers have found that premature births were more likely in women prescribed asthma medicines compared with women who were not.…
Half of asthma patients in the UK overusing SABAs, study finds In a UK asthma programme, 284,683 out of 574,913 patients were found to be “potentially overusing” short-acting β2-agonists.…
Top ten opinion pieces of 2020 Our news and views team has worked hard to keep you in the loop during a year full of twists and turns. And there’s been no shortage of COVID-19 developments for our opinion leaders to analyse, or pharmacy predictions to ponder.…
Personalised medicine approach could benefit people with asthma Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.…
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research finds A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.…
